I like to think about technology and how it can improve our health and our sustainable future.



I was previously a healthcare investor at Bain Capital. Prior to that, I worked at Blackstone on European financial restructuring and at Goldman Sachs and the World Health Organization. My work has been published in Science, JAMA, and the New England Journal of Medicine and cited by the Wall Street Journal, Washington Post, and Le Figaro. I graduated from Harvard, where I studied Biomedicine.

The empirical findings of this study raise interesting issues about the future of drug development . . .
— Dr. Robert Califf, Commissioner of the FDA, et al.